<?xml version="1.0" encoding="UTF-8"?>
<p id="p0195">In a study of 1099 patients in China, 41.3% of confirmed COVID-19 patients (454/1099) and 35.7% of nonsevere patients (331/926) received oxygen therapy.
 <xref rid="bib1" ref-type="bibr">
  <sup>1</sup>
 </xref> WHO guidelines recommend that supplemental oxygen therapy be given to patients with severe acute respiratory infection (SARI), respiratory distress, hypoxemia, or shock.
 <xref rid="bib21" ref-type="bibr">
  <sup>21</sup>
 </xref> However, there are no restrictions on which patients can receive supplemental oxygen therapy in the Chinese guidelines,
 <xref rid="bib20" ref-type="bibr">
  <sup>20</sup>
 </xref> which may have resulted in the overuse of oxygen therapy. In general, patients with blood oxygen saturation (SPO
 <sub>2</sub>) â‰¥ 93% do not require supplemental oxygen, and hyperoxemia may induce further respiratory injury and even higher mortality.
 <xref rid="bib29" ref-type="bibr">
  <sup>29</sup>
 </xref> The indications for supplemental oxygen should be carefully applied in patients with COVID-19.
 <xref rid="bib21" ref-type="bibr">
  <sup>21</sup>
 </xref>
</p>
